Why the study?
Does long-term dexamethasone correct hypertension and restore aldosterone responsiveness in patients with glucocorticoid-suppressible hyperaldosteronism?
Does long-term dexamethasone correct hypertension and restore aldosterone responsiveness in patients with glucocorticoid-suppressible hyperaldosteronism?
Long-term physiological dexamethasone therapy corrects hypertension and restores normal renin-angiotensin-aldosterone axis regulation in patients with glucocorticoid-suppressible hyperaldosteronism.
Answers are grounded in this paper and cite their sources.
May support physiological-dose dexamethasone for sustained control in glucocorticoid-suppressible hyperaldosteronism; leaves open confirmation in controlled trials.
Two males with glucocorticoid-suppressible hyperaldosteronism had hyperaldosteronism, hypertension and hypokalaemia corrected by continuous administration of physiological doses of dexamethasone for more than a year. During long-term dexamethasone treatment: (a) Plasma renin activity increased from subnormal to high normal levels, with normal posture-mediated increases; (b) Plasma aldosterone became responsive to angiotensin infusion, a new observation; (c) A fall in plasma aldosterone between 0800 h (recumbent) and 1000 h (upright) was replaced by a rise; (d) Plasma aldosterone became suppressible with salt loading. These findings are consistent with a shift to more normal control of aldosterone by renin-angiotensin, once abnormal responsiveness to ACTH has been nullified.
No takes yet. Share an insight, caveat, or question.
Woodland et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: